Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Clinical Trials in China

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 08 Nov 2026, 03:17 UTC
19187
Studies in scope
all four open statuses
11790
Recruiting now
open to new participants
2028
Lead sponsors
across recruiting studies
Top sites
Beijing 5576 Shanghai 3879 Guangzhou 3345 Hangzhou 1819 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University481 Fudan University478 Second Affiliated Hospital, Zhejiang University, School of Medicine401 Ruijin Hospital289 Peking Union Medical College Hospital279
Site location
Beijing5576 Shanghai3879 Guangzhou3345 Hangzhou1819 Wuhan1343
All 625 locations
Target enrolment
to

Trials in this register

19187 of 19187 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Minimally Residual of Esophageal Cancer 001
NCT05952661Esophageal Carcinoma, Minimal Residual Disease
Hebei Medical University Fourth Hospital
Observational
56
Shijiazhuang
2023-02-22
Recruiting
Zhejiang University
Phase 2
50
Hangzhou
2023-02-22
Recruiting
Shanghai AbelZeta Ltd.
Phase 1/2
112
Beijing, Chongqing, Guangzhou, Hangzhou, Jinan, Nanchang, Nanjing, Shanghai
2023-02-22
Recruiting
Xijing Hospital of Digestive Diseases
Phase 3
150
Lanzhou, Guangzhou, Nanjing, Shenyang, Xi'an, Chengdu, Tianjin
2023-02-22
Recruiting
Shared Decision Making in Patients With Lung Cancer
NCT05191485Surgery, Lung Adenocarcinoma
Sichuan Cancer Hospital and Research Institute
Observational
190
Chengdu
2023-02-22
Active, closed
Guangzhou Lupeng Pharmaceutical Company LTD.
Phase 2
62
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou, Guangzhou, Meizhou
2023-02-21
Active, closed
AskGene Pharma, Inc.
Phase 1/2
62
Beijing
2023-02-21
Active, closed
A Study of GNC-038 Injection in Patients With Relapsed or Refractory NK/ T-cell Lymphoma, AITL, and Other NHL
NCT05627856NK/T Cell Lymphoma, Vascular Immunomother T Cell Lymphoma, Non-Hodgkin Lymphoma
DrugGNC-038
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1/2
4
Guangzhou
2023-02-21
Recruiting
First Affiliated Hospital of Chongqing Medical University
Phase 1/2
520
Chongqing
2023-02-20
Recruiting
ACOART AVF RENEW: A Post Market Clinical Study
NCT06205576Stenosis of Native Hemodialysis Arteriovenous Fistulas
Acotec Scientific Co., Ltd
Not applicable
164
Beijing
2023-02-20
Recruiting
ctDNA-guided Adjuvant Chemotherapy in Liver Metastasis of Colorectal Cancer
NCT05815082Colorectal Cancer, Liver Metastases, Circulating Tumor Cell, Chemotherapy Effect
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3
490
Guangzhou
2023-02-20
Active, closed
Chigenovo Co., Ltd
Phase 1/2
24
Beijing, Chengdu, Tianjin
2023-02-20
Recruiting
Shanghai Tong Ren Hospital
Phase 2
58
Changzhou, Chengdu, Ch’ang-ch’un, Ha’erbin, Hefei, Jiaxing, Lanzhou, Ningbo
2023-02-20
Recruiting
Observational Cohort Study of Chronic Viral Infection in the Central Nervous System
NCT07512518Progressive Multifocal Leukoencephalopathy, Immune Checkpoint Inhibitors
Peking Union Medical College Hospital
Observational
66
Beijing
2023-02-20
Recruiting
Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA
NCT05797077Colorectal Cancer, Liver Metastases, Circulating Tumor Cell, Cancer, Therapy-Related
DrugCapecitabine
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3
346
Guangzhou
2023-02-20
Recruiting
Beijing Disability Risk and Ageing Monitoring Study
NCT06394817Age Problem, Disability, Death
Xuanwu Hospital, Beijing
Observational
2,000
Beijing
2023-02-20
Recruiting
The Proactive Ophthalmic Examination Cohort
NCT05851287Vision Impairment, Eye Diseases
Zhongshan Ophthalmic Center, Sun Yat-sen University
Observational
5,000
Guangzhou
2023-02-20
Recruiting
The Correlation Between Blood Concentration of Sintilimab and Efficacy and Adverse Reactions in Patients with Advanced Gastric Cancer
NCT06702683Gastric Carcinoma, Gastric Neoplasm, Gastric (cardia, Body) Cancer, Gastric Cancer Adenocarcinoma Metastatic
Lin Liu
Observational
112
Nanjing
2023-02-17
Active, closed
Ruijin Hospital
Observational
112
Shanghai
2023-02-17
Recruiting
Chongqing Adrenogenic Autonomic Cortisol Secretion Cohort Study
NCT05743933Diagnosis, Treatment, Adrenogenic Autonomic Cortisol Secretion
Chongqing Medical University
Observational
200
Chongqing
2023-02-17
Not yet open
Tianjin Medical University
Observational
1,200
Lanzhou, Ürümqi
2023-02-17
Recruiting
Xijing Hospital of Digestive Diseases
Phase 2/3
104
Beijing, Guangzhou, Zhengzhou, Changsha, Nanjing, Shenyang, Xi'an, Yan’an
2023-02-17
Recruiting
Stent Implantation Versus Medical Therapy for Idiopathic IntracraniaL Hypertension (SIMPLE)
NCT05707442Idiopathic Intracranial Hypotension, Venous Sinus Stenosis
Beijing Tiantan Hospital
Phase 3
74
Beijing
2023-02-16
Recruiting
Submental Flap for the Reconstruction of Hypopharyngectomy
NCT06161779Head and Neck Cancers - Hypopharyngeal
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
40
Guangzhou
2023-02-16
Recruiting
Zhongnan Hospital
Phase 2
35
Wuhan
2023-02-16
Recruiting
Fujian Cancer Hospital
Phase 1/2
51
Fuzhou
2023-02-16
Recruiting
Dizal Pharmaceuticals
Phase 2
60
Shanghai
2023-02-15
Active, closed
AstraZeneca
Phase 3
214
Beijing, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Harbin, Jinan
2023-02-15
Recruiting
Sun Yat-sen University
Observational
30
Guangzhou
2023-02-15
Recruiting
Dual-targeting VEGFR1 and PD-L1 CAR-T for Pleural, Peritoneal, or Leptomeningeal Metastases
NCT05477927Malignant Peritoneal Effusion, Malignant Ascites, Serous Cavity Metastatises, Leptomeningeal Metastases
Sichuan University
Phase 1
40
Chengdu
2023-02-15
Recruiting
Sunshine Lake Pharma Co., Ltd.
Phase 2
110
Beijing
2023-02-15
Recruiting
Fudan University
Phase 3
307
Shanghai
2023-02-15
Active, closed
Qilu Pharmaceutical Co., Ltd.
Phase 3
606
Guangzhou
2023-02-15
Active, closed
Janssen Research & Development, LLC
Phase 3
12,523
Anyang, Baoji, Baotou, Beijing, Changchun, Changsha, Chengdu, Chenzhou
2023-02-15
Active, closed
Merck Sharp & Dohme LLC
Phase 3
377
Hefei, Beijing, Wanzhou, Fuzhou, Guangzhou, Jiangmen, Shenzhen, Wuhan
2023-02-14
Recruiting
A Study to Assess Safety and Preliminary Efficacy of LP-108 Combined With Azacitidine In Subjects With AML, MDS, CMML
NCT05641259Acute Myeloid Leukemia, Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia
DrugAzacitidine
Guangzhou Lupeng Pharmaceutical Company LTD.
Phase 1
198
Nanchang, Suzhou, Zhengzhou
2023-02-14
Recruiting
Ruijin Hospital
Phase 1/2
264
Shanghai
2023-02-13
Active, closed
Shanghai Junshi Bioscience Co., Ltd.
Phase 1
104
Beijing
2023-02-13
Active, closed
A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A
NCT05685238Haemophilia A, Haemophilia A With Inhibitors
Novo Nordisk A/S
Phase 3
451
Beijing, Guangzhou, Wuhan, Changsha, Jinan, Chengdu, Tianjin, Huzhou
2023-02-13
Recruiting
Zhao Jun
Observational
50
Suzhou
2023-02-12
Recruiting
Concomitant Hybrid Versus Catheter Ablation for Atrial Fibrillation With Hypertrophic Cardiomyopathy
NCT05610215Atrial Fibrillation, Cardiomyopathy, Hypertrophic, Radiofrequency Ablation
China National Center for Cardiovascular Diseases
Not applicable
66
Beijing
2023-02-11
Active, closed
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1/2
7
Beijing, Guangzhou, Zhengzhou
2023-02-10
Active, closed
Qilu Hospital of Shandong University
Phase 2
55
Jinan, Qingdao, Yantai
2023-02-10
Recruiting
The Impact of Semaglutide Compared to Energy Restriction on Type 2 Diabetes
NCT07272343Type 2 Diabetes Mellitus (T2DM), Semaglutide, Caloric Restriction
DrugSemaglutide
Second Affiliated Hospital of Nanchang University
Phase 4
100
Jiangxi
2023-02-10
Active, closed
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1/2
70
Shanghai
2023-02-10
Active, closed
Takeda
Phase 2
52
Beijing, Changchun, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Hefei
2023-02-10
Recruiting
Clinical Trial of the Safety and Efficacy of Peripheral Nerve Stimulation in the Treatment of Peripheral Neuropathic Pain.
NCT06290661Postherpetic Neuralgia, Peripheral Neuropathic Pain, Trigeminal Neuralgia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
60
Wuhan
2023-02-09
Recruiting
Zhejiang ACEA Pharmaceutical Co. Ltd.
Phase 1/2
84
Beijing, Guangzhou, Hangzhou
2023-02-09
Recruiting
Accelerated Intermittent Theta-Burst Stimulation Ameliorate Major Depressive Disorder by Regulating CAMKII Pathway
NCT05913960Major Depressive Disorder, Major Depressive Disorder, Recurrent
First Affiliated Hospital of Zhejiang University
Not applicable
90
Hangzhou
2023-02-09
Active, closed
AstraZeneca
Phase 2
51
Beijing, Chengdu, Fuzhou, Guangzhou, Kunming, Ningbo, Shijiazhuang, Suzhou
2023-02-09
Active, closed
Xiamen Ophthalmology Center Affiliated to Xiamen University
Early Phase 1
11
Xiamen
2023-02-08
Active, closed
Genmab
Phase 3
900
Beijing, Fuzhou, Xiamen, Guangzhou, Shijiazhuang, Harbin, Zhengzhou, Wuhan
2023-02-08
Active, closed
West China Hospital
Phase 1
6
Chengdu
2023-02-08
Active, closed
West China Hospital
Phase 1
19
Chengdu
2023-02-08
By invitation
Tianjin Anding Hospital
Observational
230
Tianjin
2023-02-07
Active, closed
Study of ST-1898 in Advanced Renal Cell Carcinoma
NCT06127238Advanced Renal Cell Carcinoma
DrugST-1898
Beijing Scitech-Mq Pharmaceuticals Limited
Phase 1/2
90
Beijing
2023-02-07
Recruiting
Zhejiang University
Observational
108
Hangzhou
2023-02-07
Recruiting
Juventas Cell Therapy Ltd.
Phase 1/2
47
Hefei, Chongqing, Guangzhou, Wuhan, Nanjing, Xuzhou, Nanchang, Tianjin
2023-02-07
Recruiting
Yongtao Sun
Phase 4
2,000
Jinan
2023-02-07
Active, closed
Cadonilimab for PD-1/PD-L1 Blockade-refractory, MSI-H/dMMR, Advanced Colorectal Cancer
NCT05426005Colorectal Cancer Stage IV, Mismatch Repair-deficient (dMMR), Microsatellite Instability-high (MSI-H)
DrugCadonilimab
Sun Yat-sen University
Phase 1/2
28
Guangzhou
2023-02-07
Recruiting
Children's Cancer Group, China
Phase 3
200
Shanghai, Chengdu
2023-02-06
Recruiting
Chengdu Origen Biotechnology Co., Ltd.
Phase 1/2
42
Beijing
2023-02-06
Active, closed
Merck Sharp & Dohme LLC
Phase 3
614
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Guangzhou, Nanning, Harbin
2023-02-06
Recruiting
Huang YuGuang
Not applicable
590
Beijing
2023-02-06
Recruiting
Peking University Cancer Hospital & Institute
Early Phase 1
24
Beijing
2023-02-06
Recruiting
Ruijin Hospital
Phase 2
55
Shanghai
2023-02-06
Active, closed
Applied Pharmaceutical Science, Inc.
Phase 1
108
Shanghai
2023-02-06
Active, closed
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2
24
Guangzhou
2023-02-05
Active, closed
Assessment of DOT Spectacles in Chinese Children
NCT05562622Juvenile Myopia, Myopia
SightGlass Vision, Inc.
Not applicable
195
Changsha, Chengdu, Guangzhou, Shanghai, Tianjin
2023-02-05
Recruiting
Effects of COPD Standardized Management on COPD Exacerbation
NCT04664491Chronic Obstructive Pulmonary Disease
China-Japan Friendship Hospital
Not applicable
3,456
Beijing
2023-02-04
Recruiting
A Real-world Study of Nitric Oxide Generator and Delivery System
NCT05703191Pulmonary Hypertension of Newborn
Novlead Inc.
Observational
10
Guangzhou
2023-02-03
Recruiting
Circulating Tumor DNA-guided Neoadjuvant Treatment Strategy for Locally Advanced Rectal Cancer
NCT05601505Locally Advanced Rectal Carcinoma, Circulating Tumor DNA
Peking Union Medical College Hospital
Phase 2
470
Beijing
2023-02-03
Active, closed
Novartis Pharmaceuticals
Phase 3
226
Beijing, Guangzhou, Shenzhen, Shijiazhuang, Luoyang, Zhengzhou, Changzhou, Nanchang
2023-02-03
Active, closed
Peking Union Medical College Hospital
Phase 1/2
30
Beijing
2023-02-02
Recruiting
Peking Union Medical College Hospital
Observational
60
Beijing
2023-02-02
Active, closed
Novartis Pharmaceuticals
Phase 3
152
Guangzhou, Wuhan, Binzhou, Hangzhou, Beijing, Jinan, Tianjin
2023-02-02
Recruiting
Zhongshan People's Hospital, Guangdong, China
Observational
12,000
Zhongshan
2023-02-01
Recruiting
Different Methods of Aerosolized Polymyxin B Inhalation for Treating Carbapenem-Resistant Gram-Negative Bacterial Pneumonia.
NCT07086391Carbapenem-Resistant Enterobacteriaceae Infection, Pneumonia - Bacterial
Fujian Medical University Union Hospital
Observational
144
Fuzhou
2023-02-01
Recruiting
Remimazolam for Postoperative Atrial Fibrillation
NCT05891145Coronary Artery Bypass Grafting, Remimazolam
DrugsRemimazolam·Midazolam
Yangzhou University
Not applicable
50
Yangzhou
2023-02-01
Recruiting
Peking Union Medical College Hospital
Not applicable
100
Beijing
2023-02-01
Recruiting
Xiangya Hospital of Central South University
Not applicable
258
Changsha
2023-02-01
Recruiting
Immune Oncology Research Institute
Observational
300
2023-02-01
Active, closed
Sanofi
Phase 3
91
Beijing, Guangzhou, Jinan
2023-02-01
Recruiting
AI-Driven Prediction of Hospital-Acquired Infections With EHR
NCT06791382Hospital-acquired Infections
The Eye Hospital of Wenzhou Medical University
Observational
1,000,000
Wenzhou
2023-02-01
Recruiting
Sun Yat-sen University
Phase 2
36
Guangzhou
2023-02-01
Recruiting
Autoimmune Hepatitis Cohort in China
NCT05785793Autoimmune Hepatitis
Shanghai Jiao Tong University School of Medicine
Observational
1,000
Shanghai
2023-02-01
Recruiting
Shanghai Zhongshan Hospital
Not applicable
200
Shanghai
2023-02-01
Recruiting
Shanghai Zhongshan Hospital
Not applicable
300
Shanghai
2023-02-01
Recruiting
Frontera Therapeutics
Early Phase 1
18
Beijing, Shanghai
2023-02-01
Active, closed
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
3,700
Hangzhou
2023-02-01
Active, closed
Xuebo Liu
Observational
301
Shanghai
2023-02-01
Recruiting
Xuanwu Hospital, Beijing
Not applicable
126
Beijing
2023-02-01
Recruiting
Juan Kang
Observational
300
Chongqing
2023-02-01
Recruiting
Beijing Hospital
Not applicable
88
Beijing
2023-02-01
Recruiting
Zhejiang Cancer Hospital
Phase 2
63
Hangzhou
2023-02-01
Active, closed
Peking Union Medical College Hospital
Phase 2
47
Beijing
2023-02-01
Recruiting
Fudan University
Phase 2
200
Shanghai
2023-02-01
Recruiting
Peking Union Medical College Hospital
Not applicable
100
Beijing
2023-02-01
Recruiting
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2
30
Nanjing, Nanning
2023-02-01
Recruiting
Shanghai Jiao Tong University School of Medicine
Phase 2
100
Shanghai
2023-02-01
Recruiting
Real-world Study Optimizing Nucleotide-analogues
NCT05937178Hepatitis B, Chronic
Huashan Hospital
Observational
20,000
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou, Nanning, Guiyang
2023-01-31
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 3
130
Nanjing
2023-01-31
Recruiting
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2
62
Guangzhou
2023-01-31
Recruiting
Shandong Boan Biotechnology Co., Ltd
Phase 1
177
Beijing
2023-01-31
Recruiting
Radiomics-based Malnutrition for Cervical Cancer.
NCT05709769Cervical Cancer, Malnutrition
Zhejiang Provincial People's Hospital
Observational
150
Hangzhou
2023-01-31
Recruiting
Shanghai Jiao Tong University School of Medicine
Early Phase 1
6
Shanghai
2023-01-30
Active, closed
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
Phase 3
990
Chengdu
2023-01-30
Active, closed
BeiGene
Phase 1/2
113
Hefei, Beijing, Fuzhou, Quanzhou, Xiamen, Guangzhou, Shantou, Zhengzhou
2023-01-29
Recruiting
Study of Comparing of With and Without Sequential Therapy of S-1
NCT05813015Locally Advanced Gastric Adenocarcinoma, Chemotherapy Effect
DrugsTegafur Gimeracil Oteracil·Teysuno·Docetaxel
Zhejiang University
Phase 3
70
Hanzhou
2023-01-28
Recruiting
NKG2D-CAR-NK92 Cells Immunotherapy for Solid Tumors
NCT05528341Relapsed/Refractory Solid Tumors
Henan Medical University
Phase 1
20
Xinxiang
2023-01-26
Recruiting
Chinese PLA General Hospital
Phase 1/2
15
Beijing
2023-01-20
Active, closed
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
50
Beijing
2023-01-20
Recruiting
High-resolution Magnetic Resonance Imaging of Intracranial Atherosclerotic Plaques in Ischemic Stroke
NCT05897645Stroke, Intracranial Atherosclerosis, High Resolution Magnetic Resonance Imaging
General Hospital of Shenyang Military Region
Observational
2,110
Shenyang
2023-01-19
Recruiting
Aibin Liang，MD，Ph.D.
Phase 1/2
48
Shanghai
2023-01-18
Active, closed
Shenzhen TargetRx Co., Ltd.
Phase 2
164
Guangzhou
2023-01-18
Active, closed
The Branch-based Intraoperative Stent System in the Treatment of Stanford A Aortic Dissection（BROAD）
NCT05659641Aortic Dissection, Aneurysm, Dissecting, Aneurysm, Vascular Diseases
Permed Biomedical Engineering Co., Ltd
Not applicable
259
Hefei, Chongqing, Fuzhou, Shijiazhuang, Harbin, Wuhan, Nanjing, Nanchang
2023-01-18
Recruiting
Clinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS Patients
NCT05923905Sporadic and Familial Amyotrophic Lateral Sclerosis
Peking University Third Hospital
Phase 4
64
Beijing
2023-01-18
Active, closed
Klus Pharma Inc.
Phase 2
240
Guangzhou, Nanning, Wuhan, Changsha, Changchun, Dalian, Weifang, Xi’an
2023-01-17
Recruiting
The FAVOR V AMI Trial
NCT05669222ST-Segment Elevation Myocardial Infarction, Multivessel Coronary Artery Disease, Percutaneous Coronary Intervention
China National Center for Cardiovascular Diseases
Not applicable
5,000
Beijing
2023-01-17
Recruiting
Abion Inc
Phase 2
178
2023-01-17
Recruiting
Guangzhou Sinogen Pharmaceutical Co., Ltd
Phase 1/2
70
Guangzhou, Harbin, Changsha, Shanghai, Chengdu
2023-01-16
Active, closed
ABTECT - Maintenance
NCT05535946Ulcerative Colitis
DrugObefazimod
Abivax S.A.
Phase 3
1,116
Wuhu, Beijing, Fuzhou, Guangzhou, Luoyang, Zhengzhou, Wuhan, Shenyang
2023-01-16
Recruiting
Suzhou Municipal Hospital
Phase 2
32
Suzhou
2023-01-16
By invitation
Tongji Hospital
Phase 1
9
Wuhan
2023-01-16
Recruiting
AstraZeneca
Phase 2
163
Beijing, Hangzhou, Harbin, Hefei, Kunming, Wuhan, Yinchuan, Zhengzhou
2023-01-16
Recruiting
Testicular Function and Semen Quality in Male Childhood and Adolescent Cancer Survivors
NCT06587477Cancer, Treatment-Related, Late Effect, Semen Analysis
The University of Hong Kong
Observational
200
Hong Kong
2023-01-16
Not yet open
Clinical Study of Improved BEAM Conditioning Regimen for ASCT in Lymphoma
NCT05681403Lymphoma, Autologous Hematopoietic Stem Cell Transplantation
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
53
Xi'an
2023-01-15
Recruiting
Huashan Hospital
Phase 2/3
2,442
Guiyang, Kaili, Liupanshui, Zunyi, Shanghai, Zhuji
2023-01-13
Active, closed
Bristol-Myers Squibb
Phase 3
516
Bengbu, Beijing, Xiamen, Guangzhou, Shenzhen, Baoding, Luoyang, Zhengzhou
2023-01-12
Recruiting
Tianjin Medical University Cancer Institute and Hospital
Phase 2
40
Tianjin
2023-01-12
Recruiting
Eli Lilly and Company
Phase 1
677
Beijing, Guangdong, Hangzhou, Shanghai, Tianjin, Xi'an
2023-01-12
Recruiting
TR64 in Patients With Advanced Solid Tumors
NCT05649345Advanced Solid Tumor
Tarapeutics Science Inc.
Phase 1
19
Bengbu, Shenyang
2023-01-12
Active, closed
Daiichi Sankyo
Phase 3
1,170
Beijing, Beijing Sheng, Cangzhou, Changchun, Changsha, Chengdu, Chongqing, Fuzhou
2023-01-11
Recruiting
LaNova Medicines Limited
Phase 1/2
139
Guangzhou, Wuhan, Linyi, Beijing, Shanghai
2023-01-11
Recruiting
Shandong Boan Biotechnology Co., Ltd
Phase 1
70
Harbin
2023-01-11
Active, closed
Tang-Du Hospital
Phase 2
40
Xi'an
2023-01-10
Recruiting
Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer
NCT06173986Esophageal Squamous Cell Carcinoma, Unresectable Locally Advanced Esophageal Cancer
DrugsPD-1inhibitor·Nab-paclitaxel·Cisplatin
Shanghai Chest Hospital
Phase 1/2
50
Shanghai
2023-01-10
Active, closed
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Early Phase 1
9
Shanghai
2023-01-10
Active, closed
Bristol-Myers Squibb
Phase 3
606
Beijing, Fuzhou, Guangzhou, Zhengzhou, Wuhan, Changsha, Nanjing, Nantong
2023-01-10
Active, closed
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Phase 1
72
Shenzhen
2023-01-10
Recruiting
Shanghai Proton and Heavy Ion Center
Phase 2
67
Shanghai
2023-01-10
Recruiting
Peking Union Medical College Hospital
Phase 2
60
Beijing
2023-01-09
Recruiting
ShiCang Yu
Not applicable
80
Chongqing
2023-01-09
Active, closed
BeiGene
Phase 1/2
113
Beijing, Fuzhou, Lanzhou, Guangzhou, Nanning, Zhengzhou, Wuhan, Changsha
2023-01-09
Active, closed
Zenas BioPharma (USA), LLC
Phase 3
194
Beijing, Shijiazhuang, Wuhai, Yantai, Shanghai, Taiyuan, Chengdu
2023-01-09
Active, closed
MAXVAX Biotechnology Limited Liability Company
Phase 2
1,512
Shangqiu
2023-01-08
Active, closed
Adult Spinal Muscular Atrophy (SMA) China Registry
NCT05618379Muscular Atrophy, Spinal
Biogen
Observational
200
Beijing, Fuzhou, Guangzhou, Shenzhen, Shijiazhuang, Changsha, Suzhou, Nanchang
2023-01-06
Recruiting
Transcranial Ultrasound Stimulation for Cognitive Function Modulation in Patients With Post COVID-19 Brain Fog
NCT07154199COVID-19, Brain Fog, Long COVID, Transcranial Ultrasound Stimulation
Xuanwu Hospital, Beijing
Not applicable
40
Beijing, Jining
2023-01-06
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Observational
500
Xi'an, Ankang, Changsha, Hanzhong, Jinan, Lanzhou, Weinan, Xianyang
2023-01-06
Recruiting
Akeso
Phase 3
570
Shanghai
2023-01-05
Recruiting
99mTc-P137 SPECT/CT in Prostate Cancer
NCT05672485Prostate Cancer
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
40
Xi'an
2023-01-05
Recruiting
Phase I Clinical Study of BL-M07D1 in Locally Advanced or Metastatic Digestive Tract Tumors and Other Solid Tumors
NCT05631964Locally Advanced or Metastatic Digestive Tract Tumors, Other Solid Tumors
DrugT-Bren
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
26
Shanghai
2023-01-05
Recruiting
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
NCT05378347Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder), Abdominal Aortic Aneurysm >= 5.0 Centimeters in Female (Disorder)
Medtronic Cardiovascular
Not applicable
600
2023-01-05
Recruiting
Yin Ping
Not applicable
360
Shanghai
2023-01-04
Recruiting
Oncolytic Virus Ad-TD-nsIL12 for Progressive Pediatric Diffuse Intrinsic Pontine Glioma
NCT05717699Oncolytic Virus, Diffuse Intrinsic Pontine Glioma, Adverse Drug Event
DrugAd-TD-nsIL12
Capital Medical University
Phase 1
18
Beijing
2023-01-04
Recruiting
Oncolytic Virus Ad-TD-nsIL12 for Primary Pediatric Diffuse Intrinsic Pontine Glioma
NCT05717712Oncolytic Virus, Diffuse Intrinsic Pontine Glioma, Adverse Drug Event
DrugAd-TD-nsIL12
Capital Medical University
Phase 1
18
Beijing
2023-01-04
Recruiting
AQTIS Medical B.V.
Not applicable
159
Beijing
2023-01-03
Recruiting
3D-4K-ICG Laparoscopic Gastrectomy for Gastric Cancer
NCT06161207Gastric Cancer, Surgery
Fujian Medical University
Phase 3
702
Fuzhou
2023-01-03
Active, closed
TCM Daoyin Therapy in Individuals At-risk for COPD
NCT05940480Chronic Obstructive Pulmonary Disease, Lung Diseases, Obstructive
Shanghai University of Traditional Chinese Medicine
Not applicable
60
Shanghai
2023-01-03
Recruiting
Shanghai Chest Hospital of Shanghai Jiao Tong University
Observational
38
Shanghai
2023-01-03
Recruiting
Clinical Study of OR for Second-line Treatment of Refractory MZL
NCT06134284OR Regimen for Relapsed/Refractory Marginal Zone Lymphoma
DrugsOrelabrutinib·Rituximab
Lixia Sheng
Phase 4
39
Hangzhou, Ningbo
2023-01-02
Active, closed
Second Xiangya Hospital of Central South University
Observational
200
Changsha
2023-01-01
Recruiting
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Observational
300
Shanghai
2023-01-01
By invitation
The Predictive Value of Molecular Diagnostic Techniques in the Antimicrobial- Resistance Phenotypes of Pathogens
NCT07035535Antimicrobial Drug Resistance, High-Throughput Nucleotide Sequencing
The First Affiliated Hospital with Nanjing Medical University
Observational
200
Nanjing
2023-01-01
Recruiting
Mycophenolate Mofetil in Gastrointestinal Henoch-Schonlein Purpura
NCT05951517Henoch-Schönlein Purpura, Gastrointestinal Injury, Mycophenolate Mofetil
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
24
Guangzhou
2023-01-01
By invitation
Xiaolong Yan, Dr.
Not applicable
660
Xi'an
2023-01-01
Recruiting
Hebei Medical University Fourth Hospital
Phase 1
100
Shijiazhuang
2023-01-01
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
84
Beijin
2023-01-01
Active, closed
Guangming Lu
Observational
2,000
Nanjing
2023-01-01
By invitation
Establishment and Validation of Prediction Model of Simultaneous Chemoradiotherapy for Cervical Cancer Organoids
NCT06786780Cervical Cancer Treated with Pelvic Radiotherapy, Cervical Cancers
Chongqing University Cancer Hospital
Phase 2
50
Chongqing
2023-01-01
By invitation
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase 1
240
Shanghai
2023-01-01
Recruiting
Peking University Third Hospital
Observational
200
Beijing
2023-01-01
Recruiting
Ultrasound-assisted Nasal Bone Fracture Reduction
NCT07869563Nasal Bone Fracture, Ultrasound
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
200
Hangzhou
2023-01-01
Recruiting
The Cohort Study for Asthma in China
NCT05937334Asthma, Bronchial
Beijing Chao Yang Hospital
Observational
400
Beijing
2023-01-01
Recruiting
The Eye Hospital of Wenzhou Medical University
Observational
1,000,000
Beijing
2023-01-01
Recruiting
Shanghai Cell Therapy Group Co.,Ltd
Early Phase 1
16
Shanghai
2023-01-01
Recruiting
Tang Ziren
Observational
30
Beijing
2023-01-01
Recruiting
RenJi Hospital
Observational
480
Shanghai
2023-01-01
Recruiting
Xijing Hospital
Not applicable
500
Xi'an
2023-01-01
Recruiting
Peking Union Medical College Hospital
Early Phase 1
30
Beijing
2023-01-01
Active, closed
Dong Peng
Observational
400
Chongqing
2023-01-01
Recruiting
Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma
NCT05978193Esophageal Squamous Cell Carcinoma, Esophageal Cancer, Metastatic Esophageal Squamous Cell Carcinoma
Shanghai Chest Hospital
Phase 2
100
Shanghai
2023-01-01
Recruiting
RenJi Hospital
Not applicable
12
Shanghai
2023-01-01
By invitation
Optimized PGT-M Strategy for Patients With No Proband
NCT06722313De Novo Mutation, Preimplantation Genetic Testing, Without Proband
ShangHai Ji Ai Genetics & IVF Institute
Not applicable
5
Shanghai
2023-01-01
Recruiting
Shanghai Cancer Hospital, China
Phase 3
300
Shanghai
2023-01-01
Recruiting
Feedback Loop Between Intracranial Atherosclerosis and Cerebral Small Vessel Disease
NCT05677607ICAS - Intracranial Atherosclerosis, Cerebral Small Vessel Diseases
Chinese PLA General Hospital
Observational
300
Beijing
2023-01-01
Recruiting
Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer
NCT06121700Adenocarcinoma, Stomach Neoplasm, Gastroesophageal-junction Cancer, Oligometastatic Disease
DrugsHerceptin·Trastuzumab
Fudan University
Phase 2
55
Shanghai
2023-01-01
Recruiting
First Affiliated Hospital of Zhejiang University
Not applicable
60
Hangzhou
2023-01-01
Recruiting
Peking University Third Hospital
Observational
300
Beijing
2023-01-01
Active, closed
Changhai Hospital
Not applicable
410
Shanghai
2023-01-01
Recruiting
Jingbo Chen
Observational
200
Jinan
2023-01-01
Recruiting
Fudan University
Phase 2
114
Shanghai
2023-01-01
Recruiting
Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China
NCT05672043Medulloblastoma, Central Nervous System Tumor, Pediatric, Ependymoma, Germ Cell Tumor
Beijing Tiantan Hospital
Observational
400
Beijing
2023-01-01
Recruiting
Idiopathic Generalized Epilepsy Syndromes
NCT06388174Epilepsy, Epilepsy, Idiopathic Generalized
Shen Chun-Hong
Observational
200
Hangzhou
2023-01-01
Recruiting
Real-World Study on CDK4/6 Inhibitors Combined With Endocrine Therapy and Subsequent Treatment in HR+/HER2- MBC.
NCT06033287Breast Cancer, Endocrine Therapy, CDK4/6 Inhibitors, Subsequent Treatment
Hunan Cancer Hospital
Observational
300
Changsha
2023-01-01
Recruiting
Tang-Du Hospital
Observational
300
Xi'an
2023-01-01
By invitation
Does Medial Raw Anchor Necessary During Tendon Repair Combined With Microfracture
NCT06431191Full Rotator Cuff Tear, Microfracture Procedure, Double Raw Repair, Lateral Raw Repair
Beijing Jishuitan Hospital
Not applicable
50
Beijing
2023-01-01
Recruiting
Peking University Third Hospital
Not applicable
250
Beijing
2023-01-01
Recruiting
Peking University Third Hospital
Not applicable
60
Beijing
2023-01-01
Recruiting
Prediction of Peritoneal Metastasis for Gastric Cancer Based on Radiomics
NCT05722275Gastric Cancer, Peritoneal Metastases
Chinese Academy of Sciences
Observational
400
Beijing, Fuzhou, Guangzhou, Guiyang, Kunming, Taiyuan, Zhengzhou, Zhenjiang
2023-01-01
Recruiting
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3
324
Guangzhou
2023-01-01
Recruiting
Peking Union Medical College Hospital
Observational
500
Beijing
2023-01-01
Recruiting
Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 Years
NCT06993636Kawasaki Disease, Coronary Artery Aneurysm, Rivaroxaban, Anticoagulant Drugs
Children's Hospital of Fudan University
Observational
60
Shanghai
2023-01-01
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
323
Jiangxi, Shanghai, Hangzhou
2023-01-01
Active, closed
Pacing Characteristics of a Conventional Bipolar
NCT06011252Symptomatic Bradycardia
Chang Gung Memorial Hospital
Not applicable
134
2023-01-01
Recruiting
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
3,000
Wuhan
2023-01-01
Recruiting
Zhujiang Hospital
Observational
1,000
Guangzhou
2023-01-01
Recruiting
Real-World Study of Post-Resistance Treatment Strategies in Advanced Breast Cancer Following CDK4/6i, PIK3CA Inhibitors, or T-DXd
NCT07073755Metastatic Breast Cancer, Drug Resistance, Hormone Receptor-Positive Breast Cancer, HER2-positive Breast Cancer
Hunan Cancer Hospital
Observational
200
Changsha
2023-01-01
Recruiting
Zhujiang Hospital
Observational
200
Guangzhou
2023-01-01
Active, closed
3D-CT-Based Prediction of Difficult Laryngoscopy in Infants With Pierre Robin Sequence
NCT07257276Pierre Robin Sequence (PRS), Difficult Laryngoscopy, Airway Management
Nanjing Children's Hospital
Observational
294
Nanjing
2023-01-01
Recruiting
Researching the Useful of Barb Suture in Obese Patients Undergoing Posterior Cervical Surgery
NCT05895968Cervical Spinal Stenosis, Posterior Cervical Spine Surgery, Barbed Suture
Xijing Hospital
Not applicable
60
Xi'an
2023-01-01
Recruiting
Fujian Medical University
Not applicable
50
Fuzhou
2023-01-01
By invitation
Prolonged Extubation in Gastric Cancer With OSA
NCT07362706Obstructive Sleep Apnea, Gastric Cancer (GC)
Qilu Hospital of Shandong University
Observational
240
Jinan
2023-01-01
Recruiting
Peking University Third Hospital
Observational
110
Beijing
2023-01-01
By invitation
Efficacy and Safety of Endovascular Thrombectomy in Acute Ischemic Stroke With Posterior Circulation Large Infarct
NCT06924996Acute Basilar Artery Occlusion, Posterior Circulation Large Infarct
Feng Gao
Observational
500
Beijing
2023-01-01
Recruiting
Sixth Affiliated Hospital, Sun Yat-sen University
Observational
150
Foshan, Guangzhou, Shenzhen
2023-01-01
Recruiting
Ministry of Science and Technology of the People´s Republic of China
Not applicable
300
Beijing
2023-01-01
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not applicable
204
Beijing
2023-01-01
Recruiting
Shanghai Jiao Tong University School of Medicine
Observational
633
Shanghai
2023-01-01
Recruiting
Shengjing Hospital
Not applicable
20
Shenyang
2023-01-01
Recruiting
Predicting Model Based on Evidence-based Pathological Diagnose Criteria for RCC Tumor Thrombus With IVC Wall Invasion
NCT05589207Carcinoma, Renal Cell, Tumor Thrombus, Neoplasm Invasiveness, Inferior Vena Cava Interruption
Peking University Third Hospital
Observational
232
Beijing
2023-01-01
Recruiting
Screening and Therapeutic Monitoring of Multiple Myeloma by MALDI-TOF MS Analysis
NCT05686447Monoclonal Gammopathies, Multiple Myeloma, M-protein
Zhujiang Hospital
Observational
200
Guangzhou
2023-01-01
Not yet open
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
500
Hangzhou
2023-01-01
Active, closed
Three Gorges Hospital of Chongqing University
Observational
150
Chongqing
2023-01-01
Recruiting
Peking University People's Hospital
Phase 3
96
Beijing
2023-01-01
By invitation
Tianjin Medical University Cancer Institute and Hospital
Phase 3
200
Tianjin
2023-01-01
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
100
Hangzhou
2023-01-01
Recruiting
UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases
NCT05535413Metastatic HER2 Negative Breast Carcinoma, Brain Metastases, Capecitabine, UDT1
DrugsUtidelone·Capecitabine
Hunan Cancer Hospital
Phase 1/2
30
Changsha
2023-01-01
Recruiting
Integrin αvβ6-targeted PET in Malignant Tumors
NCT05835570Malignant Neoplasm, PET/CT, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic
Zhongnan Hospital
Observational
200
Wuhan
2023-01-01
Recruiting
Guangzhou Institute of Respiratory Disease
Observational
60
Guangzhou
2023-01-01
Recruiting
Daratumumab for Patients With Light Chain Amyloidosis
NCT06376214Light Chain (AL) Amyloidosis
DrugsDara·Pomalidomide
Nanjing University School of Medicine
Not applicable
100
Nanjing
2023-01-01
Recruiting
Clinical Study of Neoadjuvant Targeted Therapy for Ameloblastoma
NCT06653517Ameloblastoma, BRAF V600E Mutation Positive
DrugsDabrafenib·Trametinib
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2
12
Shanghai
2023-01-01
Recruiting
Image Driven Hepatocellular Carcinoma Invasiveness Evaluation Research
NCT06559761Hepatocellular Carcinoma Stage III
Chinese PLA General Hospital
Observational
500
Beijing
2023-01-01
Active, closed
Beijing Neurosurgical Institute
Observational
208
Beijing
2023-01-01
Recruiting
Nanjing Children's Hospital
Not applicable
110
Nanjing
2023-01-01
Recruiting
Leflunomide for Henoch-Schonlein Purpura
NCT05937880Henoch-Schonlein Purpura
DrugLeflunomide
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
36
Guangzhou
2023-01-01
Active, closed
Minghui Li
Observational
100
Beijing
2023-01-01
Not yet open
Sichuan Provincial People's Hospital
Phase 4
344
Chongqing, Chengdu, Ya'an, Zigong
2023-01
Not yet open
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1/2
148
Beijing, Jinan, Shanghai
2023-01
Not yet open
Peking University People's Hospital
Phase 2
26
Beijing
2023-01
Recruiting
Chen KeZhong
Observational
1,800
Beijing
2022-12-31
Active, closed
Application of Multitask Deep Learning Model in Grading the Severity of Spinal Facet Joint Degeneration
NCT05635006Facet Joints; Degeneration ; Deep Learning ;Artificial Intelligence
Hai Lv
Observational
1,132
Zhuhai
2022-12-31
Active, closed
Novartis Pharmaceuticals
Phase 3
90
Guangzhou, Hangzhou, Dalian, Tianjin
2022-12-30
Not yet open
Chinese Academy of Medical Sciences, Fuwai Hospital
Not applicable
131
Beijing
2022-12-30
Recruiting
SNF Platform Study of HR+/ HER2-advanced Breast Cancer
NCT05594095Breast Neoplasm, Breast Cancer, Hormone Receptor Positive Tumor, HER2-negative Breast Cancer
DrugsCarrelizumab·SHR-A1921·SHR-A2009·Famitinib
Fudan University
Phase 2
620
Shanghai
2022-12-30
Recruiting
Tianjin Medical University Second Hospital
Phase 2
21
Tianjin
2022-12-30
Recruiting
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Phase 1
24
Jinan, Tianjin
2022-12-30
Recruiting
Erector Spinae Plane Block Improves Organ Dysfunction in Septic Patients With Acute Gastrointestinal Injury
NCT05623722Sepsis, Acute Gastrointestinal Injury, Organ Dysfunction Syndrome
Jing Cai, MD
Not applicable
116
Guangzhou
2022-12-29
Recruiting
Broadenbio Ltd., Co.
Phase 1
78
Guangzhou, Zhengzhou
2022-12-29
Recruiting
National Health Research Institutes, Taiwan
Observational
250
2022-12-29
Active, closed
AstraZeneca
Phase 3
1,350
Beijing, Changsha, Chengdu, Chongqing, Guangzhou, Hefei, Jinan, Kunming
2022-12-29
Recruiting
Chongqing University Cancer Hospital
Phase 2
33
Chongqing
2022-12-29
Recruiting
Fudan University
Early Phase 1
24
Shanghai
2022-12-28
Recruiting
Ruijin Hospital
Observational
7,062
Shanghai
2022-12-28
Recruiting
Study of ICP-723 in Patients With Advanced Solid Tumors or Primary Central Nervous System Tumors
NCT05745623Advanced Solid Tumors Harboring NTRK Fusion, Primary Central Nervous System Tumors Harboring NTRK Fusion
DrugICP-723
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 1/2
70
Guangzhou
2022-12-27
Recruiting
Anthos Therapeutics, Inc.
Phase 3
2,500
Beijing, Lanzhou, Guangzhou, Shantou, Nanning, Shijiazhuang, Wuhan, Changchun
2022-12-27
Not yet open
Cognitive Impairment Cohort Study of the Elderly Population in SheMountain
NCT05667935Alzheimer Disease, Dementia, Neurodegenerative Diseases, Cognitive Impairment
Ruijin Hospital
Observational
2,000
Shanghai
2022-12-26
Recruiting
Phase 1 Trial of KH617
NCT05667194Advanced Solid Tumors
Sichuan Honghe Biotechnology Co., Ltd.
Phase 1
45
Beijing
2022-12-26
Recruiting
Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)
NCT05917106Carcinoma, Renal Cell Carcinoma, RCC, Kidney Neoplasms
Jinling Hospital, China
Observational
450
Nanjing
2022-12-26
Recruiting
Hunan Province Tumor Hospital
Phase 2
140
Changsha
2022-12-25
Active, closed
AriBio Co., Ltd.
Phase 3
1,535
Beijing, Changchun, Changsha, Chongqing, Guangzhou, Hefei, Heping, Nanchang
2022-12-23
Recruiting
Henan Provincial People's Hospital
Phase 2
80
Zhengzhou
2022-12-23
Recruiting
Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer
NCT05757336Gallbladder Cancer, Initially Unresectable, the First Line Treatment
Lu Wang, MD, PhD
Phase 2
50
Shanghai
2022-12-22
Recruiting
Sichuan University
Phase 1/2
77
Chengdu
2022-12-22
Active, closed
First in Human Study of AZD9592 in Solid Tumors
NCT05647122Advanced Solid Tumours, Carcinoma Non-small Cell Lung, Head and Neck Neoplasms, Colorectal Neoplasms
DrugsAZD9592·Osimertinib·Leucovorin·Adrucil
AstraZeneca
Phase 1
190
Beijing, Chongqing, Guangzhou, Wuhan
2022-12-21
Recruiting
Shengjing Hospital
Phase 2
236
Shenyang
2022-12-20
Recruiting
Zhenzhen Liu
Phase 2
369
Zhengzhou
2022-12-20
Active, closed
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 1
80
Fuzhou, Changsha, Changchun, Hangzhou, Taizhou
2022-12-20
Not yet open
Henan Provincial People's Hospital
Observational
60
Zhengzhou
2022-12-20
Active, closed
Tianjin Medical University Cancer Institute and Hospital
Not applicable
60
Tianjin
2022-12-20
Active, closed
Peking Union Medical College Hospital
Phase 2
100
Beijing
2022-12-20
Recruiting
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
NCT05490472Solid Tumors, ER+ Breast Cancer, Triple Negative Breast Cancer, TNBC, ARID1A Gene Mutation
Jacobio Pharmaceuticals Co., Ltd.
Phase 1/2
102
Beijing, Changchun, Jinan
2022-12-20
Active, closed
Prognostic Value of the AMR Measured After PPCI in STEMI Patients
NCT05653765Coronary Heart Disease, ST Elevation Myocardial Infarction
Henan Institute of Cardiovascular Epidemiology
Observational
2,663
Shangqiu, Xinxiang, Yongcheng, Zhengzhou, Shanghai
2022-12-20
Recruiting
Jiangsu Healthy Life Innovation Medical Technology Co., Ltd
Phase 3
512
Harbin, Jinan, Shanghai
2022-12-20
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2/3
400
Beijing
2022-12-20
Active, closed
Amgen
Observational
7,000
Beijing, Chongqing, Dongguan, Foshan, Guangzhou, Huizhou, Zhuhai, Guilin
2022-12-19
Active, closed
Novartis Pharmaceuticals
Phase 3
20
Chongqing, Guangzhou, Chengdu, Beijing
2022-12-19
Not yet open
Henan Provincial People's Hospital
Observational
100
Zhengzhou
2022-12-17
Recruiting
Hainan Community Cognition Cohort
NCT06686186Cognitive Impairment, Dementia, Age Problems
Hainan Medical College
Observational
2,000
Haikou
2022-12-16
Recruiting
A Novel Oral Synbiotic Formula in Reducing Advanced Adenoma Recurrence and Colorectal Neoplasia-related Bacterial Gene Markers
NCT05592886Colorectal Neoplasms, Colorectal Adenoma, Colorectal Cancer, Advanced Adenoma
Chinese University of Hong Kong
Not applicable
649
Hohhot
2022-12-15
Active, closed
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 4
387
Hangzhou
2022-12-15
Recruiting
OriCell Therapeutics Co., Ltd.
Phase 1/2
105
Beijing, Changsha, Changchun, Chengdu, Hangzhou, Lishui, Shanghai
2022-12-15
Recruiting
Thrombus Imaging and Treatment Analytics in Neurology
NCT05663281Thrombus, Brain, Thrombosis
Chinese PLA General Hospital
Observational
100
Beijing
2022-12-15
Active, closed
Janssen Research & Development, LLC
Phase 3
214
Beijing, Changchun, Chengdu, Fuzhou, Guangzhou, Hangzhou, Shanghai, Suzhou
2022-12-15
Not yet open
Xiamen University
Observational
260
Xiamen
2022-12-15
Recruiting
ShiCang Yu
Not applicable
76
Chongqing
2022-12-15
Active, closed
Mechanism and Immune Function Analysis of SARS-CoV-2 Infection in Hematologic Tumors
NCT05683353SARS-CoV-2 Infection, Hematologic Malignancy
Peking University First Hospital
Observational
60
Beijing
2022-12-14
Active, closed
Bristol-Myers Squibb
Phase 2/3
230
Wuhan
2022-12-14
Recruiting
Long-term Follow-up Study of BHC001 for TDT
NCT06314529Thalassemia, Beta
Bioray Laboratories
Observational
6
Nanning, Changsha
2022-12-14
Active, closed
Amgen
Phase 3
7,297
Beijing, Guangzhou, Huizhou, Nanning, Daqing, Harbin, Nanyang, Wuhan
2022-12-14
Active, closed
Viatris Innovation GmbH
Phase 3
470
2022-12-13
Recruiting
AstraZeneca
Phase 3
3,527
Anyang, Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuyang, Guangzhou
2022-12-13
Recruiting
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
12
Shanghai
2022-12-13
Active, closed
Dizal Pharmaceuticals
Phase 3
324
Beijing, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Harbin
2022-12-13
Active, closed
Janssen Research & Development, LLC
Phase 1/2
57
Beijing, Chengdu, Chongqing, Guangzhou, Hangzhou, Huizhou, Shanghai, Shenyang
2022-12-13
Active, closed
Pei-Rong Ding
Phase 2
66
Guangzhou
2022-12-12
Active, closed
Sun Yat-sen University
Phase 2
32
Guangzhou
2022-12-12
Recruiting
Beijing Airdoc Technology Co., Ltd.
Not applicable
304
Xuzhou
2022-12-12
Recruiting
Fudan University
Phase 2
34
Shanghai
2022-12-12
Recruiting
Chinese PLA General Hospital
Phase 1/2
30
Beijing
2022-12-11
Not yet open
Henan Provincial People's Hospital
Phase 2
60
Zhengzhou
2022-12-11
Recruiting
Pfizer
Phase 3
100
Beijing, Guangzhou, Guiyang, Wuhan, Nanchang, Tianjin
2022-12-09
Active, closed
Bristol-Myers Squibb
Phase 2
189
Guangzhou, Foshan, Maoming Shi, Shenzhen Shi, Liuzhou, Nanning, Haikou, Kunming
2022-12-09
Active, closed
Novartis Pharmaceuticals
Phase 3
696
Guangzhou, Wuhan, Wuxi, Changchun, Chengdu, Hangzhou, Beijing, Shanghai
2022-12-09
Recruiting
InxMed (Shanghai) Co., Ltd.
Phase 1/2
70
Shanghai
2022-12-08
Recruiting
Qilu Pharmaceutical Co., Ltd.
Phase 3
632
Shanghai
2022-12-08
Active, closed
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 3
250
Hangzhou
2022-12-08
Active, closed
Celcuity Inc
Phase 3
701
2022-12-08
Recruiting
Jinling Hospital, China
Not applicable
236
Nanjing
2022-12-08
Recruiting
First Hospital of China Medical University
Not applicable
300
Shenyang
2022-12-07
Recruiting
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
NCT05579366High Grade Epithelial Ovarian Cancer, High Grade Serous Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer
DrugsErythromycin·Rina-S·Itraconazole·Bevacizumab
Genmab
Phase 1/2
952
Beijing, Fujian, Guangdong, Henan, Hubei, Shanxi, Shengyang, Tianjin
2022-12-07
Active, closed
Novartis Pharmaceuticals
Phase 2
95
Wuhan, Changsha, Beijing
2022-12-06
Not yet open
Qingdao Central Hospital
Phase 3
6,792
Qingdao
2022-12-06
Active, closed
Bellus Health Inc. - a GSK company
Phase 3
997
Kunshan, Leshan, Ürümqi, Beijing, Changsha, Chengdu, Chongqing, Dongguan
2022-12-05
Active, closed
AbbVie
Phase 1
288
Beijing, Wuhan, Shenyang, Shanghai
2022-12-05
Active, closed
Xijing Hospital
Phase 2
31
Xi'an
2022-12-05
Recruiting
Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics
NCT06001073Coronary Artery Disease, Arrhythmias, Cardiac, Heart Valve Diseases, Aortic Dissection
First Affiliated Hospital Xi'an Jiaotong University
Observational
25,000
Xi'an
2022-12-05
Recruiting
Zhongshan Ophthalmic Center, Sun Yat-sen University
Observational
604
Guangzhou
2022-12-05
Active, closed
Zhongshan Ophthalmic Center, Sun Yat-sen University
Not applicable
110
Guangzhou
2022-12-05
Recruiting
Tianjin Medical University Cancer Institute and Hospital
Phase 2
100
Tianjin
2022-12-02
Recruiting
FengYan Jin
Not applicable
41
Changchun
2022-12-02
Recruiting
Neoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLC
NCT06241807IMMUNOTHERAPY, Neoadjuvant Therapy, Resectable Lung Non-Small Cell Carcinoma, Biomarkers / Blood
DrugCamrelizumab
Shandong Cancer Hospital and Institute
Phase 2
30
Jinan
2022-12-02
Not yet open
Renmin Hospital of Wuhan University
Observational
300
Wuhan
2022-12-01
Recruiting
Fourth Affiliated Hospital of Guangxi Medical University
Not applicable
288
Baise City, Guilin, Liuzhou, Nanjing, Qinzhou, Wuzhou
2022-12-01
Recruiting
Xuanwu Hospital, Beijing
Observational
16,000
Beijing, Changchun, Chengdu, Suzhou
2022-12-01
Recruiting
National Natural Science Foundation of China
Observational
1,600
Fujian, Shanhai, Shenzhencun
2022-12-01
Not yet open
Henan Provincial People's Hospital
Phase 2
70
Zhengzhou
2022-12-01
Recruiting
Huashan Hospital
Observational
1,255
Lanzhou, Harbin, Hohhot, Suzhou, Xuzhou, Shenyang, Jinan, Jining
2022-12-01
Recruiting
Biao Zou
Not applicable
30
Wuhan
2022-12-01
Not yet open
Peking University
Phase 2
54
Beijing
2022-12-01
Recruiting
Construction of a Database for TMA
NCT05634928Thrombotic Microangiopathies
The First Affiliated Hospital of Soochow University
Observational
500
Suzhou
2022-12-01
Recruiting
A Study on Diagnosis and Treatment Strategies for Atlantoaxial Dislocation
NCT06233539Atlantoaxial Dislocation, Treatment, Diagnostic
Peking University Third Hospital
Observational
3,000
Beijing
2022-12-01
Not yet open
Women's Hospital School Of Medicine Zhejiang University
Not applicable
140
Hangzhou
2022-12-01
Not yet open
A Combination Therapy Including Anti-PD-1 Immunotherapy in MSS Rectal Cancer With Resectable Distal Metastasis
NCT05359393Advanced Rectal Cancer, Liver Metastasis, Pulmonary Metastasis, Microsatellite Stable Colorectal Carcinoma
Fudan University
Phase 2
52
Shanghai
2022-12-01
Active, closed
Serplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma
NCT05659251Esophageal Squamous Cell Carcinoma, Neoadjuvant Therapy
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
48
Hangzhou
2022-12-01
Recruiting
Jiangsu Famous Medical Technology Co., Ltd.
Phase 3
730
Nanjing
2022-12-01
Recruiting
The First Affiliated Hospital of Xiamen University
Phase 2
66
Xiamen
2022-12-01
Recruiting
The First Affiliated Hospital of University of South China
Phase 4
312
Hengyang
2022-12-01
Recruiting
The Affiliated Hospital of Xuzhou Medical University
Phase 1
20
Xuzhou
2022-12-01
Not yet open
Nanjing University of Traditional Chinese Medicine
Not applicable
90
Nanjing
2022-12-01
Recruiting
Deep Enhanced Imaging in Stroke and Vascular Neurology
NCT05614193Radiology, Cerebral Stroke, Vascular Diseases
Chinese PLA General Hospital
Observational
1,000
Beijing
2022-12-01
Not yet open
Henan Provincial People's Hospital
Observational
50
Zhengzhou
2022-12-01
Active, closed
To Explore the Influencing Factors and Solutions for Patients With Plaque Psoriasis Undergoing Relapse
NCT07730619Plaque Psoriasis, Biologic Agents, Relapse, Influence Factors
First Affiliated Hospital Xi'an Jiaotong University
Observational
140
Xi'an
2022-12-01
Recruiting
Ningbo No. 1 Hospital
Phase 1
24
Hangzhou, Ningbo
2022-12
Recruiting
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
4,500
Changzhou, Huai'an, Nanjing, Suqian, Suzhou
2022-12
Recruiting
Gene Therapy in Subjects With Biallelic RPE65 Mutation-associated Retinal Dystrophy
NCT05858983Biallelic RPE65 Mutation-associated Retinal Dystrophy
Frontera Therapeutics
Phase 1/2
9
Beijing
2022-11-30
Not yet open
Sun Yat-sen University
Not applicable
236
Guangzhou
2022-11-30
Active, closed
Pfizer
Phase 1
148
Hangzhou, Wenzhou
2022-11-30
Active, closed
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 2
321
Guangzhou
2022-11-30
Recruiting
Bio-Thera Solutions
Phase 1
182
Chongqing, Hangzhou
2022-11-30
Active, closed
AstraZeneca
Phase 3
1,174
Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou
2022-11-28
Recruiting
Huazhong University of Science and Technology
Phase 2
41
Wuhan
2022-11-26
Recruiting
Artificial Intelligence System for Early Warning of Adverse Events in Acute Myocardial Infarction
NCT07139860Acute Myocardial Infarction With ST Elevation, Intelligent Management Platform, Early Warning
Hui Chen
Observational
1,400
Beijing
2022-11-26
Recruiting
The Registry Study of Genetic Alterations of Oropharyngeal Cancer in Taiwan
NCT05522881Oropharyngeal Squamous Cell Carcinoma
National Health Research Institutes, Taiwan
Observational
410
2022-11-25
Active, closed
Sun Yat-sen University
Phase 2
41
Guangzhou
2022-11-25
Active, closed
Sanofi
Phase 2
187
Guangzhou, Hangzhou, Hefei, Nanchang, Nanjing, Shanghai, Shenyang
2022-11-25
Recruiting
Peijia Medical Technology (Suzhou) Co., Ltd.
Not applicable
120
Suzhou
2022-11-24
Active, closed
A Study Evaluating Cadonilimab Injection in Combination With Regorafenib for the Advanced Hepatocellular Carcinoma
NCT05644379Advanced Hepatocellular Carcinoma That Has Failed at Least One Prior Systemic Therapy
DrugsRegorafenib·Cadonilimab
Tianjin Medical University Cancer Institute and Hospital
Phase 1
30
Tianjin
2022-11-24
Recruiting
Jinling Hospital, China
Phase 2
30
Nanjing
2022-11-23
Recruiting
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 1/2
150
Beijing
2022-11-23
Recruiting
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
566
Guangzhou
2022-11-23
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
260
Beijing, Changchun, Changsha, Chengdu, Fuzhou, Hangzhou, Jinan, Qingdao
2022-11-21
Recruiting
Effects and Safety of Diabetic GUideline Algorithm Implementation Performed by Primary Care Physicians in the Community
NCT05349955Type 2 Diabetes, Cardiovascular Complication, Diabetic Kidney Disease
Shanghai Zhongshan Hospital
Not applicable
5,600
Suzhou
2022-11-21
Active, closed
Compression Therapy as a Prophylactic Method Against CIPN: a Prospective Self-controlled Trial
NCT05531916Nasopharyngeal Carcinoma, CIPN - Chemotherapy-Induced Peripheral Neuropathy
Sun Yat-sen University
Not applicable
182
Guangzhou
2022-11-21
Active, closed
Regeneron Pharmaceuticals
Phase 3
63
Shanghai
2022-11-21
Recruiting
Zhongnan Hospital
Observational
80
Wuhan
2022-11-20
Recruiting
The Affiliated Hospital of Qingdao University
Phase 3
616
Qingdao
2022-11-20
Active, closed
Primary Cervical Cancer Screening by Self-sampling HPV Test
NCT05613283Human Papillomavirus Infection, Cervical Cancer, Negative For Intraepithelial Lesion Or Malignancy, Atypical Squamous Cells of Undetermined Significance
Peking University People's Hospital
Observational
17,875
Beijing, Zhengzhou, Changsha, Chengdu, Hangzhou
2022-11-19
Active, closed
Digital Therapy for Fatty Liver Disease
NCT07007741Steatohepatitis, Nonalcoholic, Nonalcoholic Fatty Liver
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
141
Shanghai
2022-11-19
Active, closed
Repeated Low-Level Red-Light Therapy for Shortening Axial Length
NCT05550740High Myopia, Refractive Errors, Eye Diseases
Shanghai Eye Disease Prevention and Treatment Center
Not applicable
30
Shanghai
2022-11-19
Recruiting
C2 Esophageal Squamous Epithelium Dysplasia
NCT05349240Esophageal Squamous Epithelium Dysplasia
Pentax Medical
Not applicable
129
Beijing, Changchun, Changzhi, Shijiazhuang
2022-11-18
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
140
Hangzhou
2022-11-18
Recruiting
Shanghai Jiatan Pharmatech Co., Ltd
Phase 1/2
100
Changchun
2022-11-18
Recruiting
Hoffmann-La Roche
Phase 1/2
65
Chengdu, Guangzhou, Nanning
2022-11-16
Active, closed
AstraZeneca
Phase 2
47
Beijing, Changsha, Chongqing, Hangzhou, Jinan, Kunming, Nanchang, Ningbo
2022-11-15
Recruiting
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 1/2
222
Beijing
2022-11-15
Recruiting
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 2
70
Hefei, Beijing, Fujian, Fuzhou, Foshan, Guangzhou, Shijiazhuang, Harbin
2022-11-15
Active, closed
Xiang Wei
Not applicable
100
Wuhan
2022-11-15
Recruiting
Study of NY-ESO-1 TCR-T in Advanced Soft Tissue Sarcoma
NCT05620693Advanced Soft-tissue Sarcoma
DrugNY-ESO-1 TCR-T
Shenzhen University General Hospital
Not applicable
20
Shenzhen
2022-11-11
Recruiting
Tianjin Anding Hospital
Observational
300
Tianjin
2022-11-11
Recruiting
Janssen Research & Development, LLC
Phase 2
520
Baoding, Changchun, Chengdu, Chongqing, Guangzhou, Hangzhou, Harbin, Huizhou
2022-11-11
Recruiting
Wei Jiang
Phase 3
440
Guilin, Wuzhou
2022-11-11
Recruiting
Shanghai AbelZeta Ltd.
Phase 1/2
92
Tianjin
2022-11-11
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
100
Xi'an
2022-11-10
Recruiting
Pfizer
Phase 3
1,060
Beijing, Fuzhou, Guangzhou, Wuhan, Nanjing, Suzhou, Changchun, Shanghai
2022-11-10
Active, closed
AstraZeneca
Phase 3
368
Beijing, Guangzhou, Hangzhou, Nanjing, Shanghai, Shenyang, Tianjin, Wuhan
2022-11-10
Active, closed
AK112 in Advanced Non-Small Cell Lung Cancer
NCT05499390Advanced Non-small-cell Lung Cancer
DrugsIvonescimab·Pembrolizumab
Akeso
Phase 3
398
Shanghai
2022-11-09
Active, closed
Chengdu Zenitar Biomedical Technology Co., Ltd
Phase 2
74
Shanghai, Chengdu
2022-11-08
Active, closed
Phase II Study of Hemay005 in Patients With Active Ulcerative Colitis
NCT05486104Moderate to Severe Ulcerative Colitis
DrugMufemilast
Ganzhou Hemay Pharmaceutical Co., Ltd
Phase 2
92
Hefei, Fuzhou, Guangzhou, Zhengzhou, Wuhan, Changsha, Nanchang, Shenyang
2022-11-08
Active, closed
A Comparison of Contact Aspiration Versus Stent Retriever for Acute Basilar Artery Occlusion
NCT05615038Basilar Artery Occlusion, Endovascular Treatment
Beijing Tiantan Hospital
Not applicable
338
Hefei, Beijing, Anyang, Zhangzhou, Baotou
2022-11-07
Recruiting
Bai-Rong Xia
Phase 2
37
Hefei
2022-11-06
Active, closed
Bayer
Phase 1
284
Beijing, Shenzhen, Hangzhou
2022-11-04
Active, closed
Bioray Laboratories
Phase 1/2
39
Guangzhou, Guanzhou, Shenzhen, Nanning, Changsha, Tianjin
2022-11-02
Active, closed
Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Locally-advanced Esophageal Squamous Cell Cancer (RICE)
NCT05621707Esophageal Squamous Cell Carcinomas, Concurrent Chemoradiotherapy, Immunotherapy, Chemotherapy
DrugVenetocalx
Shanghai Chest Hospital
Phase 2
50
Shanghai
2022-11-02
Recruiting
Second Affiliated Hospital of Guangzhou Medical University
Phase 3
187
Guangzhou
2022-11-02
Not yet open
Xuanwu Hospital, Beijing
Not applicable
6
Beijing
2022-11-01
Recruiting
Ming-Yuan Chen
Not applicable
384
Zhuhai
2022-11-01
Recruiting
PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally Advanced ESCC (NEOCRTEC2101)
NCT05357846Squamous Cell Esophageal Carcinoma, Esophageal Cancer, Oesophageal Cancer
DrugsTaxol·Sintilimab·Paclitaxel·Cisplatin
Sun Yat-sen University
Phase 3
422
Guangzhou
2022-11-01
Active, closed
Additional Consolidative Esophagectomy for the Patients With Oligometastatic Resectable ESCC
NCT05951127Esophageal Squamous Cell Carcinoma, Oligometastatic Disease
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not applicable
141
Beijing
2022-11-01
Recruiting
Cognitive Decline and Underlying Mechanisms in Symptomatic Intracranial Artery Stenosis Patients: A Cohort Study
NCT06336174Intracranial Atherosclerosis, Cognitive Impairment, Cerebrovascular Event
Anhui Medical University
Observational
100
Hefei
2022-11-01
Recruiting
Xiangya Hospital of Central South University
Observational
5,000
Hunan
2022-11-01
Not yet open
Fujian Medical University
Phase 3
216
Fuzhou
2022-11-01
Recruiting
Hepatitis B Vaccination After Neonatal Surgery
NCT06023056Vaccination Reaction, Hepatitis B Virus Infection, Digestive System Disorders of Fetus and Newborn, Blood Transfusion Complication
Children's Hospital of Chongqing Medical University
Observational
180
Chongqing
2022-11-01
Active, closed
First Affiliated Hospital of Zhejiang University
Phase 2
30
Hangzhou
2022-11-01
By invitation
Peking University International Hospital
Phase 4
102
Beijing, Qingdao, Shanghai, Xi’an
2022-11-01
Recruiting
Shanghai University of Traditional Chinese Medicine
Observational
100
Changsha, Shanghai
2022-11-01
Recruiting
West China Hospital
Phase 2
35
Chengdu
2022-11-01
Recruiting
Institute of Hematology & Blood Diseases Hospital, China
Observational
50
Tianjin
2022-11-01
Recruiting
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
NCT05582499Breast Neoplasm, Breast Cancer, Breast Tumors, Triple-Negative Breast Cancer (TNBC)
DrugsSHR-4602·IBI354·JSKN003·TQB2868
Fudan University
Phase 2
716
Shanghai
2022-11-01
Not yet open
Sintilimab Plus NCT or NCRT Versus NCRT for ESCC
NCT05244798Esophageal Squamous Cell Carcinoma
DrugSintilimab
Sichuan Cancer Hospital and Research Institute
Phase 3
420
Chengdu
2022-11-01
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 2
50
Nanjing
2022-11-01
Active, closed
Safety and Efficacy of Daratumumab in Patients With Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorders
NCT05403138Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder, NMO Spectrum Disorder
DrugsDarzalex·Daratumumab
Tianjin Medical University General Hospital
Phase 2/3
135
Tianjin
2022-11-01
Recruiting
Zhongshan Ophthalmic Center, Sun Yat-sen University
Observational
600
Guangzhou
2022-11-01
Recruiting
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
59
Tianjin
2022-11-01
Active, closed
Novo Nordisk A/S
Phase 3
3,400
2022-11-01
Recruiting
Pre-operative Therapy in Breast Cancer
NCT05621564Breast Cancer
RenJi Hospital
Observational
6,032
Shanghai
2022-11-01
Recruiting
Bone Marrow Mononuclear Cells for the Repair of Severe Maxillofacial Bone Defects
NCT07852806Maxillofacial Bone Defect, Alveolar Bone Loss
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not applicable
20
Nanjing
2022-11-01
Recruiting
Study of GPC-3 CAR-T Cells in Treating With Hepatocellular Carcinoma
NCT05620706Advanced Hepatocellular Carcinoma
Shenzhen University General Hospital
Not applicable
20
Shenzhen
2022-11-01
Recruiting
Chinese University of Hong Kong
Not applicable
160
Hong Kong
2022-11-01
Recruiting
MSD R&D (China) Co., Ltd.
Phase 1/2
203
Chongqing, Guangzhou, Shijiazhuang, Harbin, Zhengzhou, Wuhan, Xuzhou, Chengdu
2022-11-01
Recruiting
Circulating Tumor DNA Guided Adjuvant Chemotherapy for Colon Cancer
NCT05529615Colon Cancer, Circulating Tumor DNA
Peking University Cancer Hospital & Institute
Not applicable
2,684
Beijing
2022-11-01
Recruiting
Guizhou Provincial People's Hospital
Observational
30
Guiyang
2022-11-01
Active, closed
Hoffmann-La Roche
Phase 3
68
Changsha, Chongqing, Jinan, Shanghai
2022-11-01
Recruiting
A RCT on the Preventive Effect of HFNC on Postoperative Pulmonary Complications in Patients With Gynecologic Neoplasms
NCT05526534Gynecologic Surgery, High-flow Nasal Cannula, Post-operative Pulmonary Complications
Sichuan Cancer Hospital and Research Institute
Not applicable
200
Chengdu
2022-11-01
Recruiting
Eye & ENT Hospital of Fudan University
Not applicable
111
Harbin, Jinan, Shanghai
2022-11-01
Recruiting
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
2,400
Wuhan
2022-11-01
Recruiting
Sunshine Lake Pharma Co., Ltd.
Phase 1/2
133
Hanzhou
2022-10-31
Recruiting
Guangzhou Gloria Biosciences Co., Ltd.
Phase 1/2
107
Beijing
2022-10-31
Recruiting
JenKem Technology Co., Ltd.
Phase 2
25
Beijing
2022-10-31
Recruiting
Henan Genuine Biotech Co., Ltd.
Phase 1/2
153
Beijing, Guangzhou, Zhengzhou
2022-10-31
Recruiting
Yingbin Liu, MD, PhD, FACS
Observational
1,000
Shanghai
2022-10-30
By invitation
Shanghai Changzheng Hospital
Phase 2
20
Shanghai
2022-10-28
Recruiting
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3
537
Guanzhou, Zhongshan, Shenzhen
2022-10-28
Active, closed
Jiangsu Cancer Institute & Hospital
Phase 2
55
Nanjing
2022-10-27
Active, closed
National Cancer Centre, Singapore
Phase 2
119
Beijing, Chengdu, Jinan
2022-10-26
Recruiting
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
470
Hefei, Wuhu, Beijing, Fuzhou, Guangzhou, Zhengzhou, Wuhan, Changsha
2022-10-26
Active, closed
A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
NCT05544929Carcinoma, Non-Small-Cell Lung, Cutaneous Melanoma, Carcinoma, Renal Cell, Carcinoma, Ovarian Epithelial
DrugsKeytruda·Pembrolizumab
Novartis Pharmaceuticals
Phase 1
126
Guangzhou, Beijing
2022-10-26
Active, closed
Study of BGB-11417 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
NCT05479994Leukemia, Lymphoma, Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Small Lymphocytic Lymphoma
DrugSonrotoclax
BeiGene
Phase 2
100
Hefei, Beijing, Fuzhou, Quanzhou, Zhangzhou, Lanzhou, Guangzhou, Shaoguan
2022-10-25
Recruiting
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
NCT05208762Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of the Head and Neck, Esophageal Squamous Cell Carcinoma, Triple Negative Breast Neoplasms
DrugsPF-08046054·Keytruda·Pembrolizumab
Seagen, a wholly owned subsidiary of Pfizer
Phase 1
714
Beijing, Shanghai
2022-10-25
Recruiting
Janssen Research & Development, LLC
Phase 3
1,590
Beijing, Changchun, Changsha, Changzhou, Chaoyang District, Chengdu, Chongqing, Fuzhou
2022-10-25
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
65
Beijing
2022-10-25
Recruiting
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
400
Fuzhou, Lanzhou, Guangzhou, Meizhou, Haikou, Chengde, Tangshan, Harbin
2022-10-24
Recruiting
Chaoyin Jiang
Not applicable
5,000
Haikou
2022-10-24
By invitation
Xinjian Yang
Observational
280
Beijing
2022-10-24
Active, closed
Acute Health Effects of High Temperature Exposure
NCT05575752Cardiovascular System, Respiratory System, Cognitive Function
Fudan University
Not applicable
30
Shanghai
2022-10-23
Active, closed
CCRF Inc., Beijing, China
Not applicable
1,448
Beijing
2022-10-21
Active, closed
Kaikai QIU
Not applicable
100
Ningbo
2022-10-21
Recruiting
Effective Translation of Endovascular Thrombectomy Trials Into Real-world Practice in the Asia-Pacific
NCT05578300Ischemic Stroke, Stroke, Stroke, Acute, Stroke, Ischemic
Chinese University of Hong Kong
Observational
350
Linyi, Qingdao
2022-10-21
Recruiting
Construction of a Database for TTP
NCT05571774TTP - Thrombotic Thrombocytopenic Purpura
The First Affiliated Hospital of Soochow University
Observational
500
Suzhou
2022-10-20
Active, closed
Yin Ping
Not applicable
264
Shanghai
2022-10-20
Active, closed
Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer
NCT05869123Uterine Cervical Neoplasm, Endometrial Neoplasms
Peking Union Medical College Hospital
Phase 1/2
17
Beijing
2022-10-20
Recruiting
Shengjing Hospital
Not applicable
300
Shenyang
2022-10-19
Recruiting
Zhujiang Hospital
Observational
10,000
Guangzhou
2022-10-19
Active, closed
Healthguard Biomed
Not applicable
207
Suzhou
2022-10-19
Active, closed
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
31
Tianjin
2022-10-18
Recruiting
Fudan University
Phase 2
93
Shanghai
2022-10-18
Active, closed
Bristol-Myers Squibb
Phase 2
94
Maoming, Shenzhen, Liuzhou, Nanning, Haikou, Kunming, Guangzhou
2022-10-17
Not yet open
Effect of Prebiotics on Blood Pressure Management
NCT05364736Hypertension, Gastrointestinal Microbiome
Sun Yat-sen University
Not applicable
100
Guangzhou
2022-10-17
Active, closed
Beijing Children's Hospital
Observational
1,100
Beijing
2022-10-15
Active, closed
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Observational
250
Yiwu
2022-10-15
Active, closed
LBBP as Initial Therapy in Patients With Non-ischemic Heart Failure and LBBB
NCT05572957Non-ischemic Cardiomyopathy, Heart Failure, Left Bundle-Branch Block
DrugGDMT
The First Affiliated Hospital with Nanjing Medical University
Not applicable
50
Beijing, Fuzhou, Nanjing, Dalian, Chengdu, Wenzhou
2022-10-14
Recruiting
Neuraxial Labor Analgesia and Offspring Neurodevelopment
NCT04964206Pregnant Women, Labor Pain, Analgesia, Epidural, Infants
Dong-Xin Wang
Observational
4,645
Beijing, Shenzhen
2022-10-14
Recruiting
Tianjin Medical University Cancer Institute and Hospital
Phase 2
65
Tianjin
2022-10-14
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
400
Beijing
2022-10-13
Active, closed
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2
52
Shanghai
2022-10-13
Active, closed
Janssen Research & Development, LLC
Phase 3
864
Beijing, Changchun, Changsha, Chaoyang District, Chengdu, Fuzhou, Guangzhou, Hangzhou
2022-10-13
Recruiting
Shanghai Chest Hospital
Phase 1/2
140
Shanghai
2022-10-13
Active, closed
InxMed (Shanghai) Co., Ltd.
Phase 1/2
140
Hangzhou, Bengbu, Changsha, Fuzhou, Ganzhou, Nanjing, Wuhan, Xuzhou
2022-10-12
Active, closed
InventisBio Co., Ltd
Phase 1/2
92
Hangzhou
2022-10-12
Active, closed
Gilead Sciences
Phase 3
1,021
Chengdu, Chongqing, Deyang, Fuzhou, Guangzhou, Hangzhou, Jiangxi, Jinan
2022-10-12
Recruiting
KSH01-R02-101 Solid Tumors
NCT05580796Solid Tumor
DrugKSH01
TCRx Therapeutics Co.Ltd
Early Phase 1
50
Beijing
2022-10-11
Active, closed
Eli Lilly and Company
Phase 3
15,374
Beijing, Changchun, Changping, Chengdu, Chongqing, Haikou, Harbin, Hengshui Shi
2022-10-11
Active, closed
Bayer
Phase 1
129
Guangzhou, Changchun, Linyi
2022-10-11
Active, closed
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
NCT05508789Alzheimer Disease, Dementia, Brain Diseases, Central Nervous System Diseases
DrugDonanemab
Eli Lilly and Company
Phase 3
1,500
Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou Fujian, Guangzhou, Haidian District
2022-10-10
Recruiting
Sun Yat-sen University
Observational
800
Fuzhou, Dongguan, Foshan, Guangzhou, Shantou, Shaoguan, Shenzhen, Zhongshan
2022-10-10
Recruiting
Combined Immunosuppression for Pediatric Crohn's Disease
NCT05043870Crohn Disease, Infliximab, Immunosuppression, Children, Only
DrugInfliximab
Children's Hospital of Fudan University
Phase 4
128
Shanghai
2022-10-10
Active, closed
Chinese Academy of Medical Sciences, Fuwai Hospital
Not applicable
2,900
Beijing
2022-10-10
Active, closed
Tianjin Medical University Second Hospital
Phase 2
100
Tianjin
2022-10-10
Recruiting
Multifrequency MRE in Evaluation of Chronic Kidney Diseases
NCT06202235Chronic Kidney Disease (CKD)
Shengjing Hospital
Observational
200
Shenyang
2022-10-10
Active, closed
Eli Lilly and Company
Phase 1
17
Wuhu, Changsha, Nanchang, Shanghai
2022-10-09
Recruiting
Induction Chemoimmunotherapy in Combination With Chemoradiotherapy and Consolidation Immunotherapy in Unresectable Locally Advanced Non-Small Cell Lung Cancer
NCT07632365Non-Small Cell Lung Cancer, Locally Advanced Non-Small Cell Lung Cancer, Unresectable Stage III NSCLC
Shanghai Chest Hospital
Phase 1/2
108
Shanghai
2022-10-09
Not yet open
The Affiliated Hospital of Qingdao University
Early Phase 1
10
Qingdao
2022-10-08
Active, closed
Genmab
Phase 3
72
Baoding, Beijing, Changchun, Chengdu, Dalian, Guandong, Guangxi, Hangzhou
2022-10-08
Recruiting
Shenzhen Hemogen
Early Phase 1
3
Nanning
2022-10-08
Active, closed
Eli Lilly and Company
Phase 3
8,000
Anyang, Baoding, Beijing, Changchun, Changde, Changsha, Chengdu, Deyang
2022-10-04
Recruiting
Chang Gung Memorial Hospital
Phase 2
123
2022-10-03
Active, closed
Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies
NCT05397496B-cell Non-Hodgkin Lymphoma (B-NHL), B-cell Acute Lymphoblastic Leukemia (B-ALL)
DrugPIT565
Novartis Pharmaceuticals
Phase 1
61
Beijing, Shanghai, Tianjin
2022-10-03
Recruiting
Children's Hospital of Fudan University
Observational
30
Shanghai
2022-10-01
Recruiting
Clinical Applicantion of Multi-Tracer PET/MR Imaging in Neurological Disorders/Disease
NCT06092125Alzheimer Disease, Parkinson Disease, Epilepsy, Malignant Brain Tumor
Xuanwu Hospital, Beijing
Observational
2,300
Beijing
2022-10-01
Recruiting
Epidemiology of Abdominal Aortic Aneurysm With Concomitant Primary Lung Cancer
NCT06775821Abdominal Aortic Aneurysm, Primary Lung Cancer, Prevalence
First Affiliated Hospital of Kunming Medical University
Observational
2,000
Kunming
2022-10-01
Recruiting
Treatment of Advanced Malignant Solid Tumors With Claudin18.2CAR-T
NCT05620732Advanced Pancreatic Carcinoma, Advanced Gastric Carcinoma
Shenzhen University General Hospital
Not applicable
20
Shenzhen
2022-10-01
Recruiting
CAV Regimen for R/R Ph- B-ALL
NCT05657652Acute Lymphoblastic Leukemia
The First Affiliated Hospital of Soochow University
Not applicable
36
Suzhou
2022-10-01
Recruiting
CAV Regimen for R/R AML
NCT05657639Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University
Phase 2
68
Suzhou
2022-10-01
Recruiting
Shanghai Tong Ren Hospital
Phase 4
160
Shanghai
2022-10-01
Recruiting
Fudan University
Not applicable
600
Shanghai
2022-10-01
Recruiting
GQ1001 Combined With Pyrotinib for Treatment With HER2 Positive Metastatic Breast Cancer
NCT05575804Advanced/ Metastatic Her-2 Positive Breast Cancer
DrugPyrotinib
Fudan University
Phase 1/2
32
Shanghai
2022-10-01
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
500
Hangzhou
2022-10-01
Recruiting
Affiliated Hospital of Nantong University
Not applicable
88
Nantong
2022-10-01
Not yet open
Assessment and Digital-health Based Intervention on Subclinical Organ Damage and Cardiovascular Risk in Chinese
NCT05435898Cardiovascular Diseases, Cardiovascular Morbidity, Subclinical Organ Damage, Digital Health
Shanghai 10th People's Hospital
Observational
4,000
Shanghai
2022-10-01
Recruiting
Peking University People's Hospital
Phase 2
64
Beijing
2022-10-01
Rows per page Showing 16001–16500 of 19187
Previous 31 32 33 34 35 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 8 November 2026. https://priyalifescience.com/clinical-trials-china?page=33

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 08 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in China?

11,790 of the 19,187 studies in this register are recruiting new participants as of the 08 Nov 2026, 03:17 UTC sync. A further 3,998 have not yet opened recruitment, 2,715 are active but closed to new participants, and 684 are enrolling by invitation only. Eligibility for any study is decided by its study team.

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Breast Cancer (423) Advanced Solid Tumors (187) Colorectal Cancer (179) Gastric Cancer (175) Hepatocellular Carcinoma (154) Advanced Solid Tumor (153) Non-Small Cell Lung Cancer (145) Solid Tumor (142) Acute Ischemic Stroke (140) Lung Cancer (135) Non-small Cell Lung Cancer (132) Pancreatic Cancer (131) Multiple Myeloma (128) Coronary Artery Disease (122) Prostate Cancer (110)
→

Browse trials by site location

Beijing (5576) Shanghai (3879) Guangzhou (3345) Hangzhou (1819) Wuhan (1343) Chengdu (1307) Nanjing (1211) Changsha (1154) Chongqing (1078) Fuzhou (1040) Tianjin (934) Zhengzhou (931) Hefei (896) Jinan (783) Changchun (639)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.